Therma Bright (TSE:THRM)
:THRM
Want to see TSE:THRM full AI Analyst Report?
THRM Stock Chart & Stats
C$0.06
>-C$0.01(-12.50%)
At close: 4:00 PM EST
C$0.06
>-C$0.01(-12.50%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.12
Previous CloseN/A
Volume10.00K
Average Volume (3M)50.06K
Market Cap
C$3.19M
Enterprise ValueC$3.22M
Total Cash (Recent Filing)C$36.19K
Total Debt (Recent Filing)C$40.00K
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Jul 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding58,002,876
10 Day Avg. Volume51,225
30 Day Avg. Volume50,057
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.51
Price to Sales (P/S)48.92
P/FCF Ratio-26.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Reported DebtVery low reported debt (~$40k) materially reduces near-term leverage risk and interest obligations. This structural feature gives management more optionality to prioritize operational fixes, pursue commercialization steps or negotiate financing on better terms without an immediate debt overhang.
Improving Operating Cash FlowOperating cash outflows have tightened substantially (TTM ~ -165k vs. much larger prior-year drains), indicating management has reduced cash burn through cost controls or operational adjustments. If sustained, this improvement extends runway and lowers near-term financing pressure, supporting medium-term execution.
Gross Margin RecoveryReturn to ~22% gross margin after a prior negative result suggests durable improvements in pricing, product mix, or unit costs. Sustained higher gross margins are a structural enabler of path-to-profitability, improving leverage on SG&A and reducing the scale needed to reach break-even.
Bears Say
Negative Shareholders' EquityMeaningfully negative shareholders' equity signals accumulated losses and permanent capital erosion. This structural balance-sheet weakness constrains borrowing capacity, may trigger covenant or listing risks, and increases reliance on dilutive or costly external financing to sustain operations.
Persistent Cash BurnConsistent negative operating and free cash flow across periods shows the business cannot self-fund growth or operations. Persisting cash deficits create structural financing requirements, raising dilution risk or potential solvency pressure if improved cash generation is not maintained.
Volatile, Declining Revenue And Deep LossesA declining, volatile top line combined with a ~-59% net margin reflects structural demand or commercialization challenges. Without stable revenue growth, fixed-cost absorption and margin recovery are difficult, prolonging reliance on external capital and limiting sustainable competitiveness.
Therma Bright News
THRM FAQ
What was Therma Bright’s price range in the past 12 months?
Therma Bright lowest stock price was C$0.04 and its highest was C$0.12 in the past 12 months.
What is Therma Bright’s market cap?
Therma Bright’s market cap is C$3.19M.
When is Therma Bright’s upcoming earnings report date?
Therma Bright’s upcoming earnings report date is Jul 01, 2026 which is in 20 days.
How were Therma Bright’s earnings last quarter?
Therma Bright released its earnings results on Apr 07, 2026. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Therma Bright overvalued?
According to Wall Street analysts Therma Bright’s price is currently Overvalued.
Does Therma Bright pay dividends?
Therma Bright does not currently pay dividends.
What is Therma Bright’s EPS estimate?
Therma Bright’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Therma Bright have?
Therma Bright has 58,002,876 shares outstanding.
What happened to Therma Bright’s price movement after its last earnings report?
Therma Bright reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Therma Bright?
Currently, no hedge funds are holding shares in TSE:THRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Therma Bright
Established in Toronto, Canada, in 2001 as The Jenex Corporation before rebranding to Therma Bright Inc. in February 2018, Therma Bright Inc. specializes in creating and distributing various medical and consumer health products. Their diverse offerings include rapid COVID-19 diagnostic tests like AcuVid, which screens for both antigens and antibodies. For pain relief, they provide devices such as Benepod, a hot and cold contrast therapy system designed to manage discomfort without medication. The company also addresses circulatory issues with Venowave, a medical compression pump aimed at mitigating symptoms associated with poor circulation. Furthermore, Therma Bright caters to the cosmeceutical industry with products like InterceptCS, a cold sore prevention system utilizing safe, controlled topical heat, and TherOZap, a thermal device that alleviates the pain, itching, and inflammation from insect bites and stings by reducing the inflammatory response. Their clientele spans both individual consumers and healthcare practitioners.
Technical Analysis
―
Perimeter Medical Imaging AI
―
Profound Medical
―
Theralase Technologies
―
Aquarius Surgical Technologies
―
Options Prices
Currently, No data available
---